Uni-Bio Science Group Announces 2026 Interim Results
The Laotian Times8h ago1 newsroom
GlobeVerge has tracked this story since 2h ago.
Revenue Reached HK$ 273.8M, Driven by Solid Growth from Bogutai® Innovation-Driven Transformation Progresses with Portfolio Optimization and Broader Market Access HONG KONG SAR – EQS Newswire – 26 August 2026 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the…